Assertio Therapeutics, Inc Business Finance Contracts & Agreements

54 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Assertio Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Stock Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2020
Asset Purchase Agreement between Assertio Therapeutics, Inc. and Collegium Pharmaceutical, Inc. (February 6, 2020)
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2020
Asset Purchase Agreement between Assertio Therapeutics, Inc. and Collegium Pharmaceutical, Inc. (February 6, 2020)
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
DE
2020
Asset Purchase Agreement between Assertio Therapeutics, Inc., Golf Acquiror LLC, and Celtic Intermediate S.A. (December 11, 2019)
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
DE
2019
Sixth Amendment to Note Purchase Agreement by Assertio Therapeutics, Inc. and Deerfield Private Design Fund III, L.P.
Note Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2019
Third Supplemental Indenture to 5.00% Convertible Senior Notes Due 2024 between Assertio Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2019
Third Supplemental Indenture to 5.00% Convertible Senior Notes Due 2024 between Assertio Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
DE
2019
Assertio Therapeutics, Inc. Convertible Notes Exchange Agreement with Noteholders (August 2019)
Exchange Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2019
Amendment No. 1 to Royalty Purchase and Sale Agreement and Bill of Sale among Depomed, Inc., Depo DR Sub, LLC, and PDL Investment Holdings, LLC
Modification Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2018
Depomed, Inc. Waiver and Release Agreement with Employee (Separation Date July 31, 2017)
Waiver Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2017
First Amendment to Rights Agreement between Depomed, Inc. and Continental Stock Transfer & Trust Company
Investor Rights Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2016
Pledge and Security Agreement between Depomed, Inc., Depo NF Sub, LLC, and Deerfield Private Design Fund III, L.P. (as Collateral Agent)
Pledge Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2015
Asset Purchase Agreement between Janssen Pharmaceuticals, Inc. and Depomed, Inc. dated January 15, 2015
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2015
First Supplemental Indenture to Indenture for 2.50% Convertible Senior Notes due 2021 between Depomed, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2014
Indenture Agreement between Depomed, Inc. and The Bank of New York Mellon Trust Company, N.A. dated September 9, 2014
Indenture Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2014
Asset Purchase Agreement between Nautilus Neurosciences, Inc. and Depomed, Inc. dated December 17, 2013
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2014
Royalty Purchase and Sale Agreement between Depomed, Inc., Depo DR Sub, LLC, and PDL BioPharma, Inc.
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
DE
2014
Depomed, Inc. 2004 Employee Stock Purchase Plan (As Amended February 19, 2014)
Stock Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2014
Asset Purchase Agreement among Archimedes Pharma US Inc., Archimedes Pharma Ltd., Archimedes Development Ltd., and Depomed, Inc.
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2013
Depomed, Inc. 2004 Employee Stock Purchase Plan (As Amended May 15, 2012)
Subscription Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2012
Asset Purchase Agreement between Depomed, Inc. and Xanodyne Pharmaceuticals, Inc. (June 21, 2012)
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
DE
2012
Depomed, Inc. 2004 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2012
Loan and Security Agreement among General Electric Capital Corporation, Oxford Finance Corporation, and Depomed, Inc. dated June 27, 2008
Loan Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2008
Depomed, Inc. 2004 Equity Incentive Plan (As Amended through May 23, 2008)
Equity Distribution Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2008
Depomed, Inc. 2004 Employee Stock Purchase Plan (as amended through May 31, 2007)
Stock Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2007
Depomed, Inc. Common Stock Purchase Agreement with Investor (April 20, 2007)
Purchase Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2007
Depomed, Inc. 1995 Stock Option Plan Notice of Exercise
Stock Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2007
DepoMed, Inc. 1995 Stock Option Plan Nonstatutory Stock Option Agreement with Optionee
Stock Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2007
Amendment No. 1 to Amended and Restated Management Continuity Agreement between Assertio Therapeutics, Inc. and Employee
Modification Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
DE
2019
Fifth Amendment to Note Purchase Agreement among Assertio Therapeutics, Inc., Deerfield Private Design Fund III, L.P., and Purchasers
Note Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2019
Fourth Amendment to Note Purchase Agreement by Assertio Therapeutics, Inc. and Deerfield Private Design Fund III, L.P.
Note Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2019
Amendment No. 2 to Commercialization Agreement among Assertio Therapeutics, Collegium Pharmaceutical, and Collegium NF
Modification Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2018
Amendment No. 3 to Commercialization Agreement among Assertio Therapeutics, Collegium Pharmaceutical, and Collegium NF
Modification Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2018
Waiver, Consent, and Third Amendment to Note Purchase Agreement and Partial Release of Security Interest among Depomed, Inc., Deerfield Private Design Fund III, L.P., and Others
Modification Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2018
Waiver and Second Amendment to Note Purchase Agreement by and among Depomed, Inc., Deerfield Private Design Fund III, L.P., and Purchasers (December 4, 2017)
Note Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2017
Consent and First Amendment to Note Purchase Agreement among Depomed, Inc., Deerfield Private Design Fund III, L.P., and Others
Note Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2016
Assignment and Consent Agreement among Grünenthal GmbH, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, and Depomed, Inc.
Assignment Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2015
Depomed, Inc. and Deerfield Private Design Fund III, L.P. Note Purchase Agreement (March 12, 2015)
Note Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2015
Depomed, Inc. 2.50% Convertible Senior Notes Due 2021 Underwriting Agreement
Underwriting Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2014
Amendment No. 1 to Common Stock Purchase Agreement between Depomed, Inc. and Azimuth Opportunity Ltd.
Modification Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2008